Ning-Chun Liu, based in United States, is currently a Director, Enterprise Cell and Gene Therapy at Labcorp Drug Development, bringing experience from previous roles at Bristol-Myers Squibb, Juno Therapeutics, Inc., Vium and Biotech Accelerator and Incubation Center. Ning-Chun Liu holds a 2013 - 2014 Certificate in Clinical Trials @ University of Washington. With a robust skill set that includes Molecular Biology, Biochemistry, Physiology, Cell Biology, Metabolic Syndrome and more, Ning-Chun Liu contributes valuable insights to the industry. Ning-Chun Liu has 5 emails on RocketReach.